Table 2
Factors associated with mortality in 403 symptomatic MERS-CoV cases in the Kingdom of Saudi Arabia for the period 2012 to July 2015, for whom comorbidities and the outcome were ascertained
| Unadjusted OR (95% CI) | Adjusted OR (95% CI) | |
|---|---|---|
| Age group, years | ||
| ≤19 | 0.40 (0.04, 3.95) | 0.37 (0.03, 3.95) |
| 20–39 | 0.54 (0.30, 0.96) | 0.64 (0.32, 1.27) |
| 40–59 | 1 | 1 |
| 60–79 | 2.44 (1.51, 3.93) | 1.49 (0.87, 2.56) |
| ≥80 | 6.51 (2.38, 17.82) | 4.07 (1.41, 11.78) |
| Male | 0.93 (0.60, 1.45) | 0.78 (0.45, 1.34) |
| Comorbidities | ||
| Diabetes | 1.43 (0.96, 2.11) | 0.86 (0.49, 1.52) |
| Hypertension | 2.34 (1.56, 3.49) | 1.41 (0.80, 2.48) |
| Renal disease | 1.84 (1.06, 3.18) | 1.06 (0.56, 2.03) |
| Pulmonary disease | 1.38 (0.68, 2.79) | 1.10 (0.48, 2.54) |
| Cardiac disease | 3.86 (2.25, 6.60) | 2.80 (1.52, 5.16) |
| Cancer | 6.46 (1.89, 22.10) | 5.98 (1.64, 21.79) |
| Location of acquisition | ||
| Primary | 1 | 1 |
| Secondary/household | 0.24 (0.10, 0.58) | 0.25 (0.09, 0.68) |
| Secondary/inpatient | 3.32 (1.90, 5.82) | 2.61 (1.41, 4.82) |
| Secondary/HCW | 0.10 (0.03, 0.35) | 0.17 (0.05, 0.59) |
| Unknown | 1.20 (0.63, 2.26) | 1.02 (0.50, 2.06) |
MERS-CoV, Middle East respiratory syndrome coronavirus; OR, odds ratio; CI, confidence interval; HCW, healthcare worker.